Press Release

President Muhammadu Buhari signs bill for an act to establish the Nigeria Centre for Disease Control

1 Mins read

As a demonstration of his commitment to national health security, the President of the Federal Republic of Nigeria, Muhammadu Buhari, has signed the Bill for an Act to establish the Nigeria Centre for Disease Control (NCDC).

Since its establishment in 2011, NCDC has demonstrated its capacity to protect the health of Nigerians by delivering on its core functions of preparedness, detection and response to outbreaks of infectious diseases.

This new Act which will establish NCDC as a full-fledged parastatal, will also ensure that its valuable work is sustained and supported. The Chief Executive of the agency, Dr. Chikwe Ihekweazu said “We are very grateful for Mr. President’s support in the passage of the Executive Bill. This Bill will provide Nigerians with an institute that has the capacity to ensure the country’s health security. We are also grateful to the Honourable Minister and Minister of State for Health for their support and the Senate Committee on Primary Health Care and Communicable Diseases led by Senator Mao Ohuabunwa.”

With the passage of the Bill establishing Nigeria’s national public health institute, the Federal Government of Nigeria has shown its commitment in ensuring Nigerians are well protected from the public health threat of global emerging infectious diseases. ABOUT NCDC The Nigeria Centre for Disease Control (NCDC) was established in the year 2011 in response to the challenges of public health emergencies and to enhance Nigeria’s preparedness and response to epidemics through prevention, detection, and control of communicable diseases. Its core mandate is to detect, investigate, prevent and control diseases of national and international public health importance.

Related posts
Press Release

Gavi and UNICEF welcome approval of new oral cholera vaccine

3 Mins read
Gavi, the Vaccine Alliance and UNICEF welcome the news that a new oral cholera vaccine (OCV), Euvichol-S, has now received WHO prequalification…
Press Release

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

7 Mins read
The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate Key takeaways • Participants…
Press Release

HSCL To Unveil Achievements and Insights From the Nigeria State-Led Strategic Purchasing for Family Planning, Maternal, Newborn and Child Health Project in Nigeria

2 Mins read
Health Systems Consult Limited (HSCL), a leading health and development consulting firm, committed to improving health systems in Nigeria, is set to…

Leave a Reply

Your email address will not be published. Required fields are marked *